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Defects in Adaptive Energy Metabolism with
CNS-Linked Hyperactivity in PGC-1 Null Mice
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nuclear receptors and several other transcription factors three exons encode a highly conserved region in PGC-
1, including the LXXLL motif that mediates its inter-outside the nuclear receptor superfamily. Adenoviral-
mediated or transgenic expression of PGC-1 in cul- action with many nuclear receptors. We generated
PGC-1/ mice through transgenic expression of cretured cells and in vivo leads to activation of mitochon-
drial biogenesis and increases in cellular respiration recombinase under the control of ZP3 promoter, which
is transiently activated during oocyte development(Lehman et al., 2000; Lin et al., 2002b; St-Pierre et al.,
2003; Wu et al., 1999). Consistent with a regulatory role (Lewandoski et al., 1997). PGC-1/ mice were ob-
tained from offspring of heterozygous breeding pairs.in the cellular adaptations to increased energy require-
ments, the expression of PGC-1 itself is highly regu- Homologous recombination and cre-mediated excision
events were confirmed by hybridization and PCR analy-lated in response to nutritional and environmental stim-
uli. For example, PGC-1 mRNA is strongly induced sis of genomic DNA isolated from PGC-1/, PGC-
1/, and PGC-1/ mice (see Supplemental Figuresin brown fat by cold exposure and in skeletal muscle
following bouts of physical activity (Baar et al., 2002; S1B–S1D on the Cell web site). Analysis of PGC-1 ex-
pression revealed that its mRNA was absent in skeletalGoto et al., 2000; Puigserver et al., 1998). Increased
PGC-1 levels in these tissues lead to enhanced mito- muscle and liver from PGC-1/ mice and reduced to
approximately 50% in PGC-1/ mice, as revealed bychondrial electron transport activities that enable cells
to meet rising energy demands, such as during adaptive RNA hybridization and real-time PCR analysis (Figure
1A and data not shown). As expected, no PGC-1 pro-thermogenesis in brown fat and contraction in muscle.
In addition to its role in mitochondrial biology, PGC-1 tein was detected in the nuclear extract prepared from
PGC-1/ brown fat (Figure 1B).also regulates several key metabolic programs that go
beyond simple mitochondrial biogenesis and oxidative Pups lacking PGC-1were born at the expected Men-
delian ratio, suggesting that PGC-1 is dispensable forphosphorylation. For example, PGC-1 drives expres-
sion of myofibrillar proteins characteristic of slow-twitch embryonic development. However, only half of PGC-
1/ pups survive early postnatal period and grow intomuscle fibers when expressed in fast-twitch muscle
beds of transgenic mice (Lin et al., 2002b). In the liver, adults (Supplemental Table S1). PGC-1/ mice weigh
approximately 10%–15% less than the PGC-1/ andPGC-1 mRNA level is rapidly induced following short-
term fasting (Yoon et al., 2001). Adenoviral-mediated PGC-1/ littermates at 2 months of age and are fertile.
Hematoxylin/eosin (H&E) staining of tissue sections re-expression of PGC-1 in cultured primary hepatocytes
and in live rats leads to activation of the entire program vealed normal histology in several tissues, including
heart, skeletal muscle, pancreas, and liver (Figures 1Cof gluconeogenesis and increased glucose production
(Yoon et al., 2001). In all of these cases, PGC-1 interacts and 1D and data not shown). In contrast, PGC-1/
brown fat appeared abnormal, with abundant accumula-with cell-selective transcription factors to execute these
tissue-specific functions, such as MEF2c in skeletal tion of large lipid droplets (Figures 1E and 1F), a feature
commonly associated with impaired thermogenic func-muscle and HNF4 and FOXO1 in the liver. The activities
of PGC-1 have been studied far less, but it appears to tion. Electron microscopy studies revealed no obvious
changes in the abundance and morphology of mitochon-share some but not all of these activities of PGC-1
(Lin et al., 2002a, 2003; St-Pierre et al., 2003). PGC-1 dria in brown fat and liver (data not shown). Measure-
ment of plasma and liver lipid levels shows no significantinduces mitochondrial biogenesis in several cell types
and also increases the expression of genes associated difference between wild-type (wt) and PGC-1 null mice
in the fed state, while the triglyceride content is lowerwith fatty acid oxidation in cultured liver cells or the
livers of rats. However, PGC-1 has minimal activity in in the liver of null mice in the fasted state (Supplemental
Table S2).the induction of gluconeogenic genes, indicating that
these two coactivators control overlapping but distinct
metabolic programs (Lin et al., 2003). A Critical Role for PGC-1
To date, all of the remarkable and diverse activities of in Hormone-Induced Gluconeogenesis
PGC-1 have been investigated using gain-of-function PGC-1 has been shown to influence glucose metabo-
approaches, in either cultured cells, virally transduced lism in muscle and liver. The expression of PGC-1 itself
animals, or transgenic mice. In this report, we investi- is induced in liver in response to fasting, a metabolic
gated the maintenance of glucose and energy homeo- state characterized by active glycogenolysis, gluconeo-
stasis in mice deficient in PGC-1 during fasting and genesis, and fatty acid  oxidation (Aoki, 1981). To ex-
feeding and in diet-induced obesity. Our studies demon- amine the requirement for PGC-1 in the regulation of
strate a critical role for PGC-1 in the control of cellular glucose metabolism, we measured blood glucose and
energy metabolism in several tissues; these studies also insulin levels in mice under various nutritional states.
reveal unexpected systemic compensatory mecha- There is no difference in plasma glucose levels in PGC-
nisms and pathogenesis in the absence of PGC-1. 1/, PGC-1/, and PGC-1/ mice when food is
provided ad libitum (Figure 2A). Mice deficient in
PGC-1, however, develop mild hypoglycemia after 24Results
hr of fasting. Examination of blood insulin levels revealed
that, although PGC-1/ mice are able to maintain eu-Generation of PGC-1/ mice
To generate mouse strains deficient in PGC-1 by ho- glycemia in the fed state, they do so with reduced circu-
lating insulin concentrations (Figure 2B). In contrast, nomologous recombination, a targeting plasmid was con-
structed flanking exons 3 to 5 of the PGC-1 gene with reduction in insulin levels was observed in PGC-1/
mice in the fasted state. Blood glucose levels tend toloxP sites (see Supplemental Figure S1A at http://www.
cell.com/cgi/content/full/119/1/121/DC1/). These be lower in the PGC-1/ mice after prolonged fasting
PGC-1 in the Control of Energy Metabolism
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Figure 1. Generation of PGC-1-Deficient Mice
(A) Hybridization analysis of PGC-1 mRNA in liver and skeletal muscle using a probe spanning exons 3 to 5 of PGC-1. Hybridization with
a probe specific for ribosomal protein 36B4 was included as a loading control.
(B) Immunoblotting of PGC-1 protein. Lysates containing in vitro-translated PGC-1 were used as a positive control. Note the absence of
PGC-1 protein in brown fat extracts from PGC-1/ mice.
(C and D) H&E staining of paraffin-embedded liver sections.
(E and F) H&E staining of plastic-embedded brown fat sections.
(48 hr), although the difference does not reach statisti- treatments. Basal levels of PEPCK and G6Pase mRNA
were similar in PGC-1/ and PGC-1/ hepatocytes,cal significance.
PGC-1 has been shown to control the expression of as revealed by RNA hybridization and quantitative real-
time PCR analysis (Figure 2D and data not shown). Fol-genes involved in mitochondrial fatty acid  oxidation
and oxidative phosphorylation in various cell types, in- lowing treatments with glucocorticoid and forskolin,
PGC-1/ hepatocytes exhibit a robust and dose-cluding hepatocytes. Proper mitochondrial respiration
is necessary to generate the ATP that supports the enzy- dependent increase in PEPCK and G6Pase mRNA (Fig-
ure 2D). In contrast, the induction of PEPCK and G6Pasematic function of the gluconeogenic pathway. To deter-
mine the effects of PGC-1 deficiency on mitochondrial mRNA expression is greatly diminished in hepatocytes
isolated from PGC-1/mice at all treatment conditionsrespiration, we next used an oxygen electrode to mea-
sure O2 consumption in isolated hepatocytes. Total O2 examined. These results clearly demonstrate that
PGC-1 is an essential mediator of transcriptional acti-consumption rate is reduced 17% in PGC-1/ hepato-
cytes compared to wt controls (Figure 2C). Respiration vation of gluconeogenic genes in response to hormonal
stimulation in isolated hepatocytes.due to mitochondrial proton leak is also reduced approx-
imately 20% in the PGC-1-deficient hepatocytes (Fig- To determine whether PGC-1 is necessary for gluco-
neogenesis in vivo, we examined blood glucose levelsure 2C). These data illustrate that mitochondrial function
is impaired in the hepatocytes from PGC-1/ mice. in mice following intraperitoneal injection of pyruvate,
an important substrate for this pathway. Consistent withHepatic gluconeogenesis is of major importance in
the fasted state (Hanson and Reshef, 1997; Pilkis and defects in gluconeogenic gene expression and mito-
chondrial function in the PGC-1/ hepatocytes, miceGranner, 1992) and is controlled by PGC-1 in gain-of-
function experiments (Herzig et al., 2001; Yoon et al., lacking PGC-1 have greatly reduced ability to convert
pyruvate into glucose as compared to wt littermates2001). The induction of PGC-1 and gluconeogenic
genes such as phosphoenolpyruvate carboxykinase (Figure 2E).
(PEPCK) and glucose-6-phosphatase (G6Pase) are me-
diated by a rise in the circulating concentrations of Constitutive Activation of the Hepatic
Gluconeogenic Program In Vivocounterregulatory hormones, such as glucagon and glu-
cocorticoids, and a fall in insulin levels. To determine in the Absence of PGC-1
The experiments in primary hepatocytes strongly sug-whether PGC-1 is essential for expression of this pro-
gram, we isolated primary hepatocytes from PGC-1/ gest that impaired mitochondrial function and a reduced
hepatic gluconeogenic program may be responsible forand PGC-1/ mice and examined the expression of
the PEPCK and G6Pase genes in response to hormonal fasting hypoglycemia in PGC-1/ mice. We next ex-
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Figure 2. Impaired Glucose Homeostasis and Hepatic Energy Metabolism in the Absence of PGC-1
(A) Plasma glucose levels in PGC-1/ (filled box), PGC-1/ (dotted box), and PGC-1/ (open box) in the fed and fasted (24 hr) states.
*p  0.0007.
(B) Plasma insulin concentrations in the same group of mice used in (A). *p  0.005.
(C) Total and uncoupled respiration in wt (/) and PGC-1-deficient (/) hepatocytes. O2 consumption rate was measured as described
in Experimental Procedures; the rate of PGC-1/ cells is normalized to wt values measured on the same day. *p  0.02. Data in (A)–(C)
represent mean  SEM.
(D) Defective hormone-induced gluconeogenic gene expression in hepatocytes lacking PGC-1. Primary hepatocytes were isolated from PGC-
1/ and PGC-1/ mice and treated with 0.2 	M or 1.0 	M of a combination of forskolin and dex for 3 or 6 hr before RNA isolation and
hybridization. Hybridization for ribosomal protein 36B4 mRNA was included as a loading control.
(E) Pyruvate tolerance test. Three-month-old male mice were fasted overnight before receiving intraperitoneal (i.p.) injection of a pyruvate
solution, as described in Experimental Procedures. *p  0.0002; **p  0.02.
amined the nutritional regulation of PEPCK and G6Pase mouse liver under fed conditions (Figure 3A). Notably,
expression of G6Pase in the fed state is near the levelgenes under fed and fasted states in the mice. As ex-
pected, wt mice activate multiple adaptive metabolic that is usually seen in fasted liver. These results indicate
that, although PGC-1 is not required for the expressionchanges in response to fasting (Figure 3A), as shown
by increased expression of gluconeogenic genes and of gluconeogenic and ketogenic genes, this coactivator
is essential for proper nutritional regulation of this re-those involved in fatty acid oxidation (MCAD), ketone
body synthesis (mitochondrial HMG-CoA synthase), and sponse. Since basal levels of PEPCK and G6Pase ex-
pression are similar in untreated primary hepatocytesbile acid synthesis (Cyp7a1) (Rhee et al., 2003; Shin et al.,
2003). Surprisingly, the expression of PEPCK, G6Pase, in the presence or absence of PGC-1 (Figure 2D), this
suggests very strongly that systemic signals are proba-HMG-CoA synthase, and MCAD is similar in PGC-1/
and PGC-1/ liver in the fasted state (Figure 3A). More bly responsible for the constitutive activation of these
genes under fed conditions in mice lacking PGC-1.unexpectedly, the mRNA levels of PEPCK, G6Pase, and
HMG-CoA synthase are greatly elevated in PGC-1/ The aberrant activation of PEPCK and G6Pase expres-
PGC-1 in the Control of Energy Metabolism
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Figure 3. Constitutive Activation of the Gluconeogenic Program in PGC-1-Deficient Liver
(A) Hybridization analysis of mRNAs for metabolic genes in the fed and fasted liver. Three-month-old male mice were fed ad libitum or fasted
for 24 hr before harvesting tissues for mRNA analysis.
(B) Expression of mRNAs for transcription factors that regulate hepatic metabolism. Note the dramatic induction of C/EBP mRNA in fed
PGC-1/ liver compared to wt liver.
(C) Real-time PCR analysis of mRNA levels for the C/EBP family members.
(D) PGC-1 does not coactivate C/EBP. H2.35 hepatoma cells were transiently transfected with a UAS-luciferase reporter with Gal4-DBD-
C/EBP in the presence or absence of PGC-1. Luciferase activity was measured 30 hr following transfection.
(E) Induction of endogenous gluconeogenic genes by C/EBP in primary hepatocytes. Primary hepatocytes were isolated from PGC-1/
(filled box) and PGC-1/ (open box) mouse liver and infected with adenoviruses expressing GFP or C/EBP. Total RNA were harvested
following 3 hr of treatments with 0.2 	M forskolin and 0.1 	M dex. Relative abundance of G6Pase and PEPCK mRNA was examined by real-
time PCR followed by normalization to 18S ribosomal RNA.
sion is likely due to dysregulation of one or more tran- fasting in both PGC-1/ and PGC-1/ mice. This
indicates that, although the expression of gluconeo-scription factors that can regulate the PEPCK and
G6Pase genes in the absence of PGC-1. To assess genic and ketogenic genes is dysregulated in the ab-
sence of PGC-1, the nutritional regulation of SREBP1cthis possibility, we examined mRNA levels of several
transcription factors known to have at least some con- is still intact. In contrast, there is a striking increase in
the abundance of C/EBP mRNA in PGC-1/ mousenection with this process. As shown in Figure 3B, the
expression of HNF4 and PPAR, key regulators of he- liver, precisely mirroring the aberrant expression of
PEPCK and G6Pase in the fed state (Figure 3A). C/EBPpatic metabolism in the fasted state, was comparable in
PGC-1/and PGC-1/ liver in the fed state, although is normally induced in the fasted state in wt animals but
is abnormally activated in the fed state in the null mice.the induction of HNF4 in response to fasting is blunted
in the absence of PGC-1. The mRNA levels for FOXO1 C/EBP
 is also induced in the fed liver lacking PGC-1,
while C/EBP is expressed normally with respect toand GR remain unchanged between genotypes in both
fed and fasted states (data not shown). As expected, PGC-1 genotypes. The aberrant induction of C/EBP
and C/EBP
, however, is absent when PGC-1-deficientthe expression of sterol response element binding pro-
tein 1c (SREBP1c), a central regulator of hepatic lipogen- hepatocytes are grown in cell culture, suggesting that
systemic signals are likely responsible for their in-esis (Horton et al., 2002), is suppressed in response to
Cell
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creased expression (Figure 3C). These results suggest controls (39.8%  2.8% body fat, n  5) after 16 weeks
of high-fat feeding (Figures 4B and 4C). In fact, a smallthat altered C/EBP transcription factor activities, partic-
ularly C/EBP, may potentially play a role in the constitu- but significant decrease in body fat content was ob-
served in PGC-1/ mice fed a chow diet (Figure 4C).tive activation of gluconeogenic gene expression seen
in the PGC-1-deficient mouse liver. As expected from their obesity, high-fat-fed PGC-1/
mice developed insulin resistance, as indicated by ele-
vated fasting glucose and insulin concentrations andPGC-1-Independent Activation
in vivo insulin tolerance test (Figures 4D and 4E). PGC-of Gluconeogenic Genes by C/EBP
1/ mice, however, display significantly enhanced in-C/EBP is a transcription factor that belongs to the
sulin sensitivity and improved glycemic control in a glu-basic leucine zipper family and has been shown to mod-
cose tolerance test (Figures 4E and 4F) as compared toulate the activity of the transfected PEPCK promoter in
the control mice. Similar results were seen in PGC-1/response to gluconeogenic hormones (Croniger et al.,
mice when maintained on a normal rodent chow (data1998; Park et al., 1993; Roesler, 2001). Pups lacking
not shown). These data clearly indicate that PGC-1 nullC/EBP develop severe hypoglycemia, and half of them
mice are resistant to obesity caused by high-fat feedingdied shortly after birth due to a failure to activate hepatic
and are protected from developing insulin resistancegluconeogenic gene expression and glucose production
and glucose intolerance that ordinarily accompany(Croniger et al., 1997; Liu et al., 1999). The effects of
this obesity.C/EBP on the endogenous gluconeogenic genes have
We next examined the two major arms of energy bal-not been studied. Moreover, a functional interaction be-
ance: energy intake as measured by food intake andtween C/EBP and PGC-1 has not been examined to
energy expenditure. Both PGC-1/ and PGC-1/date. As shown in Figure 3D, PGC-1 does not coacti-
mice show similar food intake at various time pointsvate C/EBP in transient transfection assays. We next
during postnatal development and high-fat feeding (Fig-ask whether C/EBP could modulate expression of en-
ure 5A and data not shown). In contrast, energy expendi-dogenous genes of gluconeogenesis and whether it
ture, measured as O2 consumption, is approximatelycould do so in the absence of PGC-1. Primary hepato-
23% higher in PGC-1/mice throughout a 3 day periodcytes were isolated from wt and PGC-1-deficient mice,
of metabolic monitoring (Figure 5B). Thus, the resistanceinfected with a recombinant adenovirus expressing a
to diet-induced obesity in PGC-1/ mice correlatescontrol GFP protein or C/EBP, and examined for the
with a substantial increase in energy expenditure.expression of PEPCK and G6Pase. As shown in Figure
3E, adenoviral-mediated expression of C/EBP acti-
vates the transcription of the G6Pase gene approxi- Reduced Thermogenic Capacity
mately 17-fold in wt hepatocytes. PEPCK mRNA level and Hyperactivity in PGC-1/ Mice
is also elevated 1.8-fold in response to ectopic C/EBP Two key components of energy expenditure are adap-
expression. Importantly, induction of gluconeogenic tive thermogenesis and physical activity. To determine
gene expression by C/EBP was also observed in the whether increased O2 consumption in PGC-1/ mice
PGC-1/ cells with a 12-fold increase in G6Pase is due to enhanced thermogenesis, we examined the
mRNA and approximately 3-fold induction of PEPCK thermogenic capacity of these animals with a standard
mRNA. The absolute levels of these mRNAs are some- cold challenge. Resting body temperature is similar be-
what higher in hepatocytes with an intact PGC-1 gene. tween PGC-1/ and PGC-1/mice (Figure 5C, t 0).
These results demonstrate that C/EBP is able to turn We next exposed 6-week-old mice to 4C and monitored
on gluconeogenic gene expression in a PGC-1-inde- their core body temperature. Both PGC-1/ and PGC-
pendent manner and strongly suggest that elevated 1/ mice respond to cold temperature by increasing
C/EBP in PGC-1/ animals may be at least partially frequency of shivering. In contrast to wt littermates,
responsible for the inappropriate activation of those glu- which are able to keep body temperature around 36.5C
coneogenic genes in the fed state. after an initial drop of approximately 1.5C, PGC-1/
mice display striking sensitivity to the cold temperature
(Figure 5C). The body temperature of PGC-1/ micePGC-1/ Mice Are Resistant
to Diet-Induced Obesity drops to 33.5C within 3 hr, and the hypothermia be-
comes lethal if the exposure of the null mice is extendedThe well-established role of PGC-1 in stimulating mito-
chondrial respiration, as well as the reduction of respira- beyond 6 hr (data not shown). Defense of body tempera-
ture in mice is mainly the function of brown adiposetion in PGC-1-deficient hepatocytes (Figure 2C) and
abnormal brown fat morphology (Figure 1D), all suggest tissue, which generates heat due in large part to abun-
dant expression of the mitochondrial uncoupler UCP1that the null mice may be prone to the development of
obesity due to reduced energy expenditure. To critically (Bouillaud et al., 1985; Jacobsson et al., 1985). Analysis
of brown fat gene expression revealed that the inductionassess this, we fed the animals a high-fat diet containing
58% of calories derived from fat. As shown in Figure 4A of UCP1 in the null mice was reduced to approximately
45% of the wt level, while the induction of type 2 iodoth-and as expected, wt mice gain substantial body weight
throughout the course of high-fat feeding. In contrast, yronine deiodinase (D2) mRNA was reduced nearly 50%
in PGC-1/ mice compared to controls (Figure 5D).PGC-1/ mice are surprisingly resistant to diet-induced
obesity (Figure 4A). Analysis of body fat content using The expression of PGC-1 is unchanged, while mRNAs
encoding several enzymes involved in mitochondriala dual energy X-ray absorptiometry (DEXA) scanner re-
vealed that PGC-1/ mice are remarkably leaner electron transport and fatty acid oxidation are reduced
in PGC-1/ brown fat (Supplemental Figure S2). These(22.6%  2.4% body fat, n  6) than the PGC-1/
PGC-1 in the Control of Energy Metabolism
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Figure 4. Resistance to Diet-Induced Obesity and Insulin Resistance in PGC-1/ mice
(A) Body weight of PGC-1/ (filled circle, n  6) and PGC-1/ (filled square, n  6) mice fed a high-fat diet. Twelve-week-old males were
fed a high-fat diet for 16 weeks. Body weight was measured weekly.
(B) Representative DEXA scanning images of PGC-1/ and PGC-1/ mice after 12 weeks of high-fat feeding.
(C) Body fat content in PGC-1/ and PGC-1/ mice under chow (4-month-old males) or high-fat feeding. Percent body fat was determined
by automated analysis of DEXA images with a program supplied by the manufacturer. *p  0.005; **p  0.001.
(D) Fasting glucose and insulin levels in high-fat-fed mice. *p  0.0001; **p  0.02.
(E) Insulin tolerance test on high-fat-fed PGC-1/ (filled circle, n  5) and PGC-1/ (filled square, n  5) mice. *p  0.004.
(F) Glucose tolerance test in high-fat-fed mice following an overnight fast. *p  0.02. Insulin and glucose tolerance tests were performed as
described in Experimental Procedures. Data in (A) and (C)–(F) represent mean  SEM.
data indicate that the increased energy expenditure in tent with this, AMP-activated protein kinase (AMPK),
a key component of cellular energy-sensing pathwaysthe PGC-1/mice is not due to increased thermogene-
sis in these animals; on the contrary, the mice are hypo- (Carling, 2004), is strongly activated in PGC-1-deficient
skeletal muscle. The levels of phosphorylated AMPKthermic when challenged.
Skeletal muscle is a major tissue involved in energy and acetyl-CoA carboxylase (ACC), a known substrate
for activated AMPK, are significantly increased in PGC-expenditure in vivo. To determine whether PGC-1 is
also required for normal mitochondrial function in skele- 1/ muscle (Figure 5F). These data clearly indicate
that PGC-1 is essential for normal mitochondrial genetal muscle, we next examined mitochondrial gene ex-
pression in quadriceps muscle from wt and PGC-1 null expression and energy metabolism in skeletal muscle.
The lack of an increase in thermogenesis or mitochon-mice. MRNA levels for a large number of genes involved
in fatty acid oxidation and mitochondrial function are drial gene expression in the mutant animals suggested
that the higher metabolic rate in PGC-1-deficient micereduced 30%–60% in PGC-1/ mice, including those
involved in intracellular fatty acid trafficking, the Kreb’s might be caused by altered levels of physical activity.
To assess this possibility, we monitored and quantitatedcycle, electron transport (Ndufb5 and Cox7a1), ATP syn-
thesis (Atp5j), and mitochondrial protein translation (Fig- the frequency of animal movements using the Compre-
hensive Lab Animal Monitoring System (CLAMS), whichure 5E and data not shown). Interestingly, the expression
of ERR, a direct target of PGC-1 and an important is capable of simultaneously recording whole-body O2
consumption and physical activity. As shown in Figuresmediator of PGC-1 action, is also reduced in the ab-
sence of PGC-1, while the PGC-1mRNA level remains 6A and 6B, a higher O2 consumption rate in PGC-1/
mice is accompanied by profound hyperactivity, as indi-largely unchanged (Figure 5E).
Impaired mitochondrial energy metabolism might be cated by increased physical movement. PGC-1-defi-
cient mice are hypermetabolic and hyperactive com-expected to negatively affect ATP/AMP ratios. Consis-
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Figure 5. Analysis of Whole-Body Energy Balance and Thermogenesis in PGC-1/ Mice
(A) Food intake was measured in a 2 day period and normalized to body weight.
(B) Whole-body O2 consumption in PGC-1/ (n  5) and PGC-1/ (n  5) mice as monitored by CLAMS. Shown is the averaged value
over 2 days and 3 nights. *p  0.006.
(C) Body temperature of 6- to 7-week-old PGC-1/ (circle, n  6) and PGC-1/ (square, n  6) mice exposed to cold temperature (4C).
Body temperature was measured with a rectal thermometer. *p  0.008. Data in (B) and (C) represent mean  SEM.
(D) Gene expression in brown fat analyzed by quantitative real-time PCR. Intrascapular brown fat was dissected from PGC-1/ (filled box)
and PGC-1/ (open box) mice maintained at 24C or after 5 hr of cold exposure at 4C. Primers specific for 18S ribosomal RNA were used
for normalization.
(E) Analysis of skeletal muscle gene expression in wt (filled box) and PGC-1-deficient (open box) mice by quantitative real-time PCR.
Quadriceps muscle was dissected from 4-month-old male mice and frozen at 80C before RNA isolation and analysis. Primers specific for
18S ribosomal RNA were used for normalization.
(F) Activation of AMPK in PGC-1/ skeletal muscle. Tissue extracts were prepared from wt or PGC-1 null quadriceps muscle and analyzed
by immunoblotting using antibodies specific for phosphorylated AMPK (pAMPK) and ACC (pACC) or an antibody that reacts with both
phosphorylated and nonphosphorylated forms of AMPK.
pared to wt controls both during daytime and at night. disorders, including stimulus-induced myoclonus, ex-
aggerated startle responses, dystonic posturing, andIn fact, the PGC-1 null mice displayed a 40% increase
in the frequency of random movements during the moni- frequent limb clasping (Figure 6D). These findings are
suggestive of lesions in the striatum, the brain area thattoring period (Figure 6C). These results strongly suggest
that much of the increase in energy expenditure seen is affected in certain neurodegenerative diseases char-
acterized by disorders of movement, including Hunting-in PGC-1/ mice is due to the hyperactivity displayed
by the null animals. ton’s disease (HD).
We assessed neuropathology in the PGC-1/
mouse brain by histological analysis. The overall brainStriatal Degeneration in PGC-1 Null Mouse Brain
Hyperactivity in PGC-1/ mice could result from al- anatomy appeared similar in the PGC-1/ and PGC-
1/ mice. However, a striking spongiform pattern oftered circulating hormones and/or signals that origi-
nated from the central nervous system. Measurements lesions was found predominantly in the striatum of
3-month-old PGC-1/ mice (Figure 7). The numberof several hormones known to influence animal move-
ment, including thyroid hormone and catecholamines, and size of lesions decrease from the dorsal to the ven-
tral side and also from the lateral to the medial partsshowed no significant alterations (Supplemental Table
S3). Besides a simple increase in total movement, we of the striatum. Occasionally, much smaller and less
abundant lesions were also found in the cortex, espe-observed that PGC-1 null mice display behavioral
changes that are characteristic of certain neurological cially in cortical layer V/VI of the motor cortex, nucleus
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Figure 6. Hyperactivity and Limb Clasping in PGC-1/ Mice
(A) Representative trace of movement monitoring for PGC-1/ (green) and PGC-1/ (red) mice over a period of 3 days.
(B) Representative trace of whole-body O2 consumption in PGC-1/ (green) and PGC-1/ (red) mice. N and D denote night and day
periods, respectively.
(C) Physical activity was measured in 3-month-old male mice with CLAMS. Shown is the average movement counts during the monitoring
period. *p  0.01.
(D) Limb clasping in PGC-1/ mice.
accumbens, thalamus, substantia nigra, hippocampus, Analysis of gene expression in the brains of wt and
mutant mice by real-time PCR revealed that mRNA lev-and the mammalliary body. The spongiform lesions in
the striatum were associated with gliosis, as indicated els of many mitochondrial genes are reduced in mutants
(Figure 8A). Interestingly, the expression of severalby strong immunoreactivity for glial fibrillary-associated
protein (GFAP), a hallmark for reactive astrocytes (Fig- brain-specific genes not involving mitochondrial func-
tion, including those encoding neurofilament proteinsures 7E and 7F). No reactive astrocytes were found in
the minor lesions in other brain areas. To determine if (NF-H and NF-M), myelin-associated oligodendrocyte
basic protein (MOBP), and Na/K ATPase (ATP1a2)the lesions were mainly affecting the white matter, brain
sections of PGC-1/ and PGC-1/ mice were is also significantly reduced in the PGC-1 null brain
compared to wt controls (Figure 8B). In contrast, mRNAstained with Luxol fast blue for myelin. As seen in Figures
7A–7D, lesions are predominantly associated with the encoding another sodium pump subunit, ATP1a1, is not
altered. These results suggest that, in addition to its keywhite matter and rarely with the gray matter. The overall
neuronal density appeared similar in wt mice and role in the regulation of mitochondrial gene expression,
PGC-1 may also have an important function in thePGC-1 null mice, although we occasionally observed
neurons containing vacuoles in PGC-1/ mouse brain. control of neuronal gene expression and function. In
fact, primary striatal neurons isolated from PGC-1/Immunostaining using a neurofilament heavy chain
(NF220) antibody showed a dramatic loss of NF220- mouse embryos display a severe impairment in neurite
growth (Figures 8C and 8D). Striatal neurons lackingpositive fibers in the striatum in the absence of PGC-
1 (Figures 7G and 7H). In fact, the spongiform lesions PGC-1 have greatly reduced branches of neurites,
whereas wt neurons exhibit robust neurite outgrowthappear to arise from the loss of axons in the striatal
area in PGC-1/ mouse brain. These results clearly and form an extensive network in culture.
demonstrate that PGC-1 is required for normal brain
function and that loss of PGC-1 leads to neuronal de- Discussion
generation in specific brain areas, most prominently in
the striatum. PGC-1 has been shown to play several important roles
in the metabolism of multiple tissues in response toPGC-1 has been shown to regulate oxidative metab-
olism and biological programs associated with in- external stimuli (Kelly and Scarpulla, 2004; Puigserver
and Spiegelman, 2003). In this paper, we have analyzedcreased oxidative capacity in a tissue-specific manner.
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Figure 7. Histological Staining of Brain Sections from Wild-Type and PGC-1 Null Mice
(A and B) Low magnification pictures showing cortex (ctx) and striatum (str) of PGC-1/ mouse brain (A) and PGC-1/ mice (B) stained
with Luxol fast blue and H&E. Note spongiform pathology predominantly in the striatum of the PGC-1/ mouse brain (red arrows). Scale
bar, 200 	m.
(C and D) High-magnification pictures of the striatum of wt (C) and PGC-1/ brains (D) stained with Luxol fast blue/H&E. Shown are spongiform
lesions in the striatum that are predominantly associated with the white matter.
(E and F) Immunohistochemical staining with an anti-GFAP antibody. Note abundant presence of reactive astrocytes (blue arrows) in the
striatum of PGC-1/ mice (F) but not in wt controls (E).
(G and H) Less striatal neurites are detected in the PGC-1/ brain (H) with a neurofilament heavy chain antibody compared to wt striatum
(G). Scale bar, 200 	m.
mice with a total deficiency of PGC-1 in order to ascer- cells can be readily isolated from this tissue, we concen-
trated much of our initial work in liver. In isolated hepato-tain its requirement in a variety of metabolic programs.
At a gross morphological level, brown adipose tissue cytes, PGC-1 is required for the execution of hormone-
mediated induction of gluconeogenic gene expression.and the brain are the only tissues that look obviously
abnormal (Figures 1 and 7). Since PGC-1 has been The isolated hepatocytes have a reduction in oxidative
metabolism, reflecting diminished mitochondrial func-shown to activate a broad program of gene expression
in liver that recapitulates the fasted/diabetic state, and tion. Surprisingly, the genes of gluconeogenesis are not
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Figure 8. Gene Expression Analysis in Mouse Brain and Neurite Growth in Cultured Primary Striatal Neurons
(A) Analysis of mitochondrial gene expression in wt (filled box, n  4) and PGC-1-deficient (open box, n  6) mouse brain by real-time PCR.
Whole brain was dissected from 3-month-old male mice and frozen at 80C before RNA isolation and analysis. Primers specific for 18S
ribosomal RNA were used for normalization. *p  0.02.
(B) Real-time PCR analysis of nonmitochondrial genes involved in normal brain function as in (A). *p  0.02.
(C and D) Wild-type and PGC-1-deficient primary striatal neurons were cultured for 4 days and stained with a monoclonal antibody against
neuron-specific class III -tubulin and Alexa Fluor 488-labeled anti-mouse IgG antibody (Green). Nuclei were stained with DAPI in the mounting
medium (blue). Note dramatically reduced neurite outgrowth in the absence of PGC-1.
only expressed in the null mice but are locked in the An intriguing issue here is how the null mice manage
to activate the gluconeogenic genes and prevent severe“on” position; the expression of PEPCK and G6Pase is
effectively uncoupled from nutritional status. Despite hypoglycemia in the absence of PGC-1. A survey of
many of the transcription factors that have been de-increased expression of mRNAs encoding gluconeo-
genic enzymes, mice deficient in PGC-1 have reduced scribed as being involved in this process shows one
that is dysregulated in parallel with the gluconeogenichepatic gluconeogenesis in vivo. Since liver is totally
dependent on the  oxidation of the fatty acids and the genes: C/EBP. We show here that C/EBP can potently
induce PEPCK and G6Pase expression and that thisoxidative phosphorylation system to generate the ATP
necessary for gluconeogenesis, the mild to moderate activation is largely independent of PGC-1. In fact,
C/EBP is slightly less effective in cells lacking PGC-fasting hypoglycemia observed in these mice most likely
occurs because of the impairment in hepatic oxidative 1, but this does not seem to be due to a loss of coactiva-
tion of C/EBP by PGC-1—PGC-1 did not coactivatemetabolism. While this manuscript was in preparation,
a study by Koo et al. showed that adenoviral-mediated C/EBP in standard transfection assays. More likely,
the effects of PGC-1 via docking on the GR, HNF-4,expression of siRNA directed toward PGC-1 in mouse
liver leads to reduced expression of gluconeogenic and FOXO1 are somewhat synergistic with an indepen-
dent action of C/EBP through its own binding sites. Agenes and lower hepatic glucose production (Koo et al.,
2004) with no apparent compensation. new model arising from these studies concerning the
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dietary control of gluconeogenesis is shown in Supple- of genes involved in oxidative metabolism and neuronal
mental Figure S3. function, there is also impaired neurite growth when
Oxidative metabolism in several tissues is reduced in striatal neurons lacking PGC-1 are cultured in vitro.
mice lacking PGC-1, but this is most apparent when The spongiform lesions observed in the striatum of
the mice are given a cold challenge. As shown in Figure PGC-1 null mouse brain seem most likely due to a loss
5C, there is a near-total collapse of this defense against of neurites in vivo; this could reflect an impairment in
the cold, and the body temperature of PGC-1 null mice energy metabolism, a problem with expression of axon-
plummets, resulting in death rather quickly. Reduced specific proteins, or both. In fact, it has been known for
mitochondrial oxidative phosphorylation in skeletal a long time that striatal neurons are exquisitely sensitive
muscle has been linked with the development of insulin to impairment in oxidative metabolism, such as those
resistance in the elderly and in offspring of diabetic caused by mitochondrial neurotoxins. The progressive
patients (Petersen et al., 2003, 2004). PGC-1 (and nature of the striatal lesions is strongly suggested by
PGC-1) has recently been shown to be deficient in the presence of reactive astrocytes and gliosis in the
the muscle of most Type 2 diabetes and prediabetics, striatum of mutant mice. Neuropathological analysis on
suggesting a very early or even causal role in the devel- mice of different ages would provide great details as
opment of this disease (Mootha et al., 2003; Patti et al., to the onset and progression of axon degeneration in
2003). Thus, examination of the role of PGC-1 in this affected brain areas.
system is of great interest, but the very large number While mice deficient in PGC-1 have an apparently
of other defects affecting systemic biology requires that complex neurological disorder, the striking hyperactivity
this be done via tissue-specific ablation of PGC-1 in with neurodegeneration is reminiscent of HD; the latter is
skeletal muscle. Examination and functional character- also accompanied by a hyperkinetic movement disorder
ization of skeletal muscle with regard to fiber types and and a progressive loss of striatal neurons. In fact, pa-
resistance to fatigue is under study, as is heart function. tients at the earliest stages of HD typically show hyper-
Given these defects in oxidative metabolism, it would activity and are usually leaner than normal individuals,
be expected that the PGC-1 null mice would be prone similar to what is shown here for the PGC-1 null mice.
to obesity and insulin resistance, but experiments with However, PGC-1 null mice exhibit spongiform lesions
high-fat feeding showed the exact opposite: the mice in the white matter, pathological findings not commonly
were resistant to obesity and insulin resistance. In this seen in mouse models of HD (Mangiarini et al., 1996;
case, a major contributing factor seems very clear—the Schilling et al., 1999). It is not yet known if the behavioral
mice are profoundly hyperactive and have an increase and movement defects shown by the PGC-1 mice are,
in energy expenditure that correlates well with their in- in fact, progressive. Whether exogenous modulation of
creased activity. It is not possible to conclude that this the pathways controlled by PGC-1 through genetic or
is the complete explanation for the leanness of the null pharmacological methods can improve brain function
mice until possible loss of calories via urinary excretion in several neurodegenerative diseases including HD also
or intestinal malabsorption is examined. remains to be determined.
The hyperactivity and behavioral changes in the
PGC-1 null mice are associated with lesions in the
Experimental Procedures
striatum, a brain area that plays a key role in motor
coordination. In fact, previous in situ hybridization analy- Generation of PGC-1 Null Mice
sis revealed that PGC-1 is abundantly expressed in A targeting plasmid was constructed using genomic DNA fragments
derived from Sv129 mouse strain. A loxP site and a neomycin/multiple brain areas such as the striatum, cerebral cor-
thymidine kinase cassette flanked by two loxP sites were introducedtex, and substantia nigra in the mouse brain (Tritos et al.,
into the PGC-1 locus. ES cell (derived from Sv129 strain) electro-2003). The prominent spongiform lesions in the striatum
poration, selection, and screening were performed using standardand, to a much less extent, in other areas of the PGC-
gene targeting techniques. Briefly, genomic DNA was isolated from
1 null mouse brain suggest that abnormal CNS function neomycin-resistant ES cell clones, digested with BamHI, and sub-
is likely underlying the hyperactivity in the null animals. jected to hybridization using probe L to detect homologous recombi-
It is possible that many of these affected neurons play nation and the presence of the flox allele (Supplemental Figure S1A).
Chimeric founders were bred with wt C57/Bl6 mice to obtain off-an inhibitory function with respect to physical move-
spring containing a germline PGC-1 flox allele. These mice werements of the mice, in that their loss is accompanied by
subsequently bred with ZP3-cre transgenic (in C57/Bl6 background)increased movement and other neurological abnormal-
mice to generate PGC-1/ offspring. The cre recombinase-medi-ities. ated generation of PGC-1/ allele was confirmed by Southern
It is rather interesting that the PGC-1-deficient mice hybridization using probe L following restriction digestion by BamHI.
show a major defect in the brain. There has been a very Heterozygous mice were mated to obtain PGC-1/ mice. Geno-
long and extensive literature concerning mitochondrial typing of mice used in this study was performed by PCR with tail
DNA as shown in Supplemental Figure S1.defects and neurodegenerative diseases (Schon and
Manfredi, 2003), so perhaps it is not entirely surprising
that lack of PGC-1, a major transcriptional regulator Animal Experiments
All animal experiments were performed according to proceduresof mitochondrial function, presents with neurological
approved by the Institutional Animal Care and Use Committee. Micedefects and histological abnormalities of the brain. Ge-
were maintained on a standard rodent chow or a high-fat diet con-netic mutations that affect mitochondrial energy metab-
taining 57% fat-derived calories (D12331, Research Diets) with 12
olism have been found to be causal in the pathogenesis hr light and dark cycles. Plasma glucose and insulin concentrations
of many forms of neurodegenerative diseases, such as were measured from tail blood using glucometer (Lifescan, Johnson
Leigh syndrome and Friedreich ataxia (Schon and Man- and Johnson) and an insulin ELISA kit (Crystal Chem Inc.), respec-
tively.fredi, 2003). In addition to alterations in the expression
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For diet-induced obesity, body weight was measured weekly for For adenoviral infection, hepatocytes were incubated with varying
titers of adenovirus expressing either GFP or C/EBP for 3 hr anda period of 4 months. Body fat content was measured using a dual
X-ray absorptiometry (Piximus, Lunar Corporation) after 3 months then maintained in starvation media for 24 hr. Infected cells were
treated with 0.2	M forskolin and 0.1	M Dex for 3 hr before RNA iso-on the high-fat diet.
For cold exposure, 6- to 7-week-old male mice were individually lation.
For respiration measurements, hepatocytes were cultured in thehoused in cages kept at 4C with free access to food and water.
Core body temperature was monitored using a rectal thermometer presence of 0.2 	M Dex overnight and then removed from plates
by incubating with the trypsin/EDTA solution. O2 consumption wasat various times after the start of cold exposure. Brown fat was
dissected 5 hr after cold exposure and subjected to gene expres- measured essentially as previously described (Fan et al., 2004; Wu
et al., 1999). Measurements were performed in the presence ofsion analysis.
Metabolic monitoring was performed using a Comprehensive Lab 25 mM glucose, 1 mM pyruvate, and 2% BSA.
Animal Monitoring System (CLAMS, Columbia Instruments) that si-
multaneously measures whole-body O2 consumption and physical Insulin/Glucose/Pyruvate Tolerance Tests
movements for 16 mice. Mice were acclimated in the monitoring For the insulin tolerance test, high-fat-fed mice were fasted for 4 hr
chambers for 2 days before the experiment to minimize the changes before receiving an intraperitoneal injection of insulin at 0.8 mU/kg.
in housing environments. Data was collected every 48 min for each Plasma glucose levels were measured from tail blood before or 15,
mouse over a period of 3 days. Metabolic rate and physical activity 30, 45, 60, and 100 min after insulin infusion.
were averaged for the whole study period with the exception of the For the glucose tolerance test, high-fat-fed mice were fasted over-
first five data points that tend to be influenced by animal handling night (14 hr) and injected intraperitoneally with a glucose solution
at the beginning of studies. (prepared in saline) at 2 g/kg. Plasma glucose levels were measured
from tail blood before or 15, 30, 45, 60, 90, and 180 min after glu-
Histological Analysis cose infusion.
Tissues were dissected and fixed in 4% paraformaldehyde overnight The pyruvate tolerance test was performed as described (Miyake
and rinsed with phosphate-buffered saline. Brown fat was subse- et al., 2002). Briefly, 3-month-old male mice were fasted for 14 hr
quently dehydrated and embedded in plastic (JB-4, Electron Micros- before receiving an intraperitoneal dose of pyruvate (in saline) at
copy Sciences) and sectioned at 1.5 	m for H&E staining. Liver was 2 g/kg. Plasma glucose levels were determined as indicated above.
dehydrated in ethanol, paraffin embedded, and sectioned at 4 	m
for H&E staining. Transient Transfection
Brain tissue for neuropathological examination was prepared from Mouse H2.35 hepatoma cells (CRL-1995, ATCC) were maintained
6- and 12-week-old wt and PGC-1 null mice. Tissues were fixed in DMEM supplemented with 4% fetal bovine serum in the presence
in situ by intracardiac perfusion with 15 ml PBS followed by 30 ml 4% of 0.2 	M dex. For transfection, 100 ng of reporter plasmid (Gal-C/
PFA in PBS. Brains were removed, postfixed in 4% PFA overnight at EBP) was transiently transfected using Superfect (Qiagen) in the
4C, and embedded in paraffin. Coronal sections (6	m) were stained presence of 500 ng of vector or pcDNA3-PGC-1. Luciferase activity
both conventionally, with H&E, Luxol fast blue (H&E  LFB), and was measured 40 hr following transfection.
0.1% cresyl echt violet (Nissl), and immunohistochemically, with
antibodies against glial fibrillary acidic protein (GFAP, polyclonal
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